Fore Biotherapeutics Opens U.S. Headquarters in Philadelphia’s Biotech Hub
Fore Biotherapeutics (formerly NovellusDx), a precision oncology company focused on providing people with rare cancer mutations rapid access to the right medicines, announced that it is…
Read More...
Read More...
